vapiprost hydrochloride events and occlusive vascular disease. Phase III trials were underway in Japan for the treatment of deep vein thrombosis. Reference standards of Vapiprost Hydrochloride API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object ( [pname] => Vapiprost Hydrochloride - API Standards [catalogue_number] => PA 22 16000 [category_ids] => ,80,78,70,82,71, [chemical_name] => [weight] => 514.10 [form] => C30H40ClNO4 [cas] => 87248-13-3 [pslug] => 87248-13-3-vapiprost-hydrochloride-api-pa2216000 [latest_product] => 0 [linkproducts] => 1 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA 22 16000
CAS :
Molecular Formula : C30H40ClNO4
Molecular Weight : 514.10
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....